ReviewCardiovascular drugs and therapy2023

Sodium-Glucose Co-transporter 2 Inhibitors Versus Metformin as the First-Line Treatment for Type 2 Diabetes: Is It Time for a Revolution?

Theocharis Koufakis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.